BRPI0715740A8 - Agente redutor de triglicerídeos séricos - Google Patents
Agente redutor de triglicerídeos séricosInfo
- Publication number
- BRPI0715740A8 BRPI0715740A8 BRPI0715740A BRPI0715740A BRPI0715740A8 BR PI0715740 A8 BRPI0715740 A8 BR PI0715740A8 BR PI0715740 A BRPI0715740 A BR PI0715740A BR PI0715740 A BRPI0715740 A BR PI0715740A BR PI0715740 A8 BRPI0715740 A8 BR PI0715740A8
- Authority
- BR
- Brazil
- Prior art keywords
- serum triglyceride
- triglyceride lowering
- agent
- lowering agent
- bacilius
- Prior art date
Links
- 210000002966 serum Anatomy 0.000 title abstract 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 title abstract 5
- 239000003795 chemical substances by application Substances 0.000 abstract 5
- 241000894006 Bacteria Species 0.000 abstract 2
- 230000037356 lipid metabolism Effects 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
AGENTE REDUTOR DE TRIGLICERÍDEOS SÉRICOS A presente invenção refere-se a agentes farmacêuticos e produtos alimentares que não têm efeitos colaterais, são fáceis de ingerir continuamente e têm um efeito redutor de triglicerídeos séricos. Apresentam-se um agente para melhorar o metabolismo lipidico e um agente redutor de triglicerídeos séricos, cada um compreendendo, como um ingrediente ativo, uma cultura de uma bactéria pertencente ao gênero Bacilius. A bactéria pertencente ao gênero Bacilius é, de preferência, Baclilus subtilis, e, mais preferivelmente, Bacilius subtilis C-3102 (FERM BP-1096). O agente para melhorar o metabolismo lipídico e o agente redutor de triglicerídeos séricos são utilizáveis para o tratamento e prevenção de doenças como arteriosclerose.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006224672 | 2006-08-21 | ||
| JP2006-224672 | 2006-08-21 | ||
| PCT/JP2007/065848 WO2008023608A1 (en) | 2006-08-21 | 2007-08-14 | Lipid-metabolism-ameliorating agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0715740A2 BRPI0715740A2 (pt) | 2013-07-16 |
| BRPI0715740A8 true BRPI0715740A8 (pt) | 2017-01-24 |
Family
ID=39106694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0715740A BRPI0715740A8 (pt) | 2006-08-21 | 2007-08-14 | Agente redutor de triglicerídeos séricos |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20100183576A1 (pt) |
| EP (1) | EP2060263A4 (pt) |
| JP (1) | JP5113057B2 (pt) |
| KR (1) | KR101454228B1 (pt) |
| CN (1) | CN101511377B (pt) |
| BR (1) | BRPI0715740A8 (pt) |
| CA (1) | CA2661373C (pt) |
| MX (1) | MX2009001782A (pt) |
| TW (1) | TW200817020A (pt) |
| WO (1) | WO2008023608A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011111783A1 (ja) * | 2010-03-12 | 2011-09-15 | カルピス株式会社 | 大腸におけるビフィズス菌の増加及び減少抑制剤 |
| JP6302183B2 (ja) * | 2013-07-12 | 2018-03-28 | 株式会社エンザミン研究所 | アディポサイトカイン産生バランス調整剤及び脂肪組織の炎症・酸化ストレス抑制剤並びに脂肪組織のマクロファージ浸潤抑制剤 |
| CN107073047B (zh) * | 2014-10-28 | 2021-08-24 | 株式会社恩基美研究所 | 胰岛素抵抗改善剂 |
| CN118638600A (zh) * | 2022-03-24 | 2024-09-13 | 浙江省农业科学院 | 具有降血脂作用的益生菌组合物的制备设备 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63209580A (ja) * | 1987-02-25 | 1988-08-31 | Karupisu Shokuhin Kogyo Kk | バチルス・ズブチリスｃ−３１０２ |
| JPH0424022A (ja) | 1990-05-21 | 1992-01-28 | Hitachi Medical Corp | 移動形ｘ線装置 |
| US5776756A (en) * | 1995-08-31 | 1998-07-07 | Toyo Hakko Co., Ltd. | Fermentation compositions having superoxide dismutating activity and an antihypertensive agent for treatment of constipation each having the superoxide dismutating activity |
| KR19990087376A (ko) * | 1996-02-29 | 1999-12-27 | 라르스 헨릭 회이에 | 식품 보충제 또는 혈청 지질 감소용 조성물 및 그의 용도 |
| JP3489930B2 (ja) * | 1996-03-08 | 2004-01-26 | 株式会社ヤクルト本社 | がん予防食品 |
| JPH10234326A (ja) * | 1997-02-26 | 1998-09-08 | Yusuke Sugaya | 新規な大豆加工食品 |
| DE69929321T2 (de) * | 1998-04-01 | 2006-09-14 | Ganeden Biotech, Inc., San Diego | Erfahren zür verringerung von cholesterin mit bacillus coagulans sporen, systeme un zusammensetzungen |
| US6811786B1 (en) * | 1999-04-01 | 2004-11-02 | Ganeden Biotech, Inc. | Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions |
| WO2000030663A1 (en) * | 1998-11-25 | 2000-06-02 | Nutri Pharma Asa | Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of type 2 diabetes, the metabolic syndrome and associated cardiovascular diseases |
| JP2004111573A (ja) * | 2002-09-17 | 2004-04-08 | Sony Corp | 半導体装置、及び同半導体装置の製造方法 |
| JP4309108B2 (ja) * | 2002-09-26 | 2009-08-05 | 大和薬品株式会社 | 糖尿病治療薬 |
| JP4503951B2 (ja) * | 2003-08-06 | 2010-07-14 | 株式会社琉球バイオリソース開発 | 糖尿病疾患予防・治療剤 |
| JP4001239B2 (ja) * | 2004-01-23 | 2007-10-31 | 国立大学法人京都大学 | ダイズ由来ペプチド混合物およびその利用 |
| JP2006111573A (ja) * | 2004-10-14 | 2006-04-27 | Ee H C:Kk | バチルス・サブチルス菌株の使用及びその使用に用いられる菌株を含む食品 |
| JP2006151952A (ja) | 2004-11-05 | 2006-06-15 | Oto Corporation:Kk | 高脂血症乃至高尿酸血症改善剤、及び、健康食品 |
-
2007
- 2007-08-14 BR BRPI0715740A patent/BRPI0715740A8/pt not_active IP Right Cessation
- 2007-08-14 US US12/438,242 patent/US20100183576A1/en not_active Abandoned
- 2007-08-14 WO PCT/JP2007/065848 patent/WO2008023608A1/ja not_active Ceased
- 2007-08-14 KR KR1020097005822A patent/KR101454228B1/ko not_active Expired - Fee Related
- 2007-08-14 CN CN2007800312533A patent/CN101511377B/zh not_active Expired - Fee Related
- 2007-08-14 JP JP2008530867A patent/JP5113057B2/ja active Active
- 2007-08-14 CA CA2661373A patent/CA2661373C/en not_active Expired - Fee Related
- 2007-08-14 EP EP07792491A patent/EP2060263A4/en not_active Withdrawn
- 2007-08-14 MX MX2009001782A patent/MX2009001782A/es active IP Right Grant
- 2007-08-20 TW TW096130744A patent/TW200817020A/zh unknown
-
2012
- 2012-03-12 US US13/418,032 patent/US20130017181A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2060263A1 (en) | 2009-05-20 |
| KR101454228B1 (ko) | 2014-10-23 |
| CN101511377B (zh) | 2012-10-03 |
| KR20090059124A (ko) | 2009-06-10 |
| US20100183576A1 (en) | 2010-07-22 |
| US20130017181A1 (en) | 2013-01-17 |
| TW200817020A (en) | 2008-04-16 |
| CA2661373A1 (en) | 2008-02-28 |
| CA2661373C (en) | 2014-10-07 |
| MX2009001782A (es) | 2009-02-25 |
| JP5113057B2 (ja) | 2013-01-09 |
| WO2008023608A1 (en) | 2008-02-28 |
| CN101511377A (zh) | 2009-08-19 |
| JPWO2008023608A1 (ja) | 2010-01-07 |
| BRPI0715740A2 (pt) | 2013-07-16 |
| EP2060263A4 (en) | 2012-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mobasheri et al. | Osteogenic effects of resveratrol in vitro: potential for the prevention and treatment of osteoporosis | |
| MX378496B (es) | Metodos para reducir riesgo de evento cardiovascular en sujeto con terapia con estatina. | |
| UA122342C2 (uk) | Спосіб інгібування всмоктування та/або прискорення виведення ліпідів за допомогою d-псикози | |
| BR112012006692A2 (pt) | composição farmacêutica compreendendo ácido graxo de omega-3 e um derivado de hidróxi de uma estatina e métodos de uso das mesmas | |
| Kilani-Jaziri et al. | Flavones induce immunomodulatory and anti-inflammatory effects by activating cellular anti-oxidant activity: a structure-activity relationship study | |
| BRPI0520669A2 (pt) | dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina | |
| CO6341563A2 (es) | Compuestos organicos | |
| EP4403213A3 (en) | Methods for reducing cardiovascular risk | |
| EA200970374A1 (ru) | Лечение антиаритмическими средствами и омега-3 жирными кислотами и их комбинированным продуктом | |
| MX2011008448A (es) | Uso de ester etilico del acido eisosapentaenoico para tratar hipertrigliceridemia. | |
| NZ618734A (en) | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas | |
| EP3318262A3 (en) | Composition for preventing or treating bone disease, obesity and lipid-related metabolic disease | |
| WO2009099830A3 (en) | Edible film-strips for immediate release of active ingredients | |
| BRPI0819690B8 (pt) | uso de uma composição compreendendo cisteamina ou cistamina, ou um sal farmaceuticamente aceitável das mesmas | |
| NO20080855L (no) | Behandling med azetidinon-baserte kolesterol absorpsjonsinhibitorer og omega-3 fettsyrer og et kombinasjonsprodukt derav | |
| UA101903C2 (ru) | Лекарственное средство на основе дииндолилметана для лечения гиперпластических и воспалительных заболеваний | |
| AR047649A1 (es) | Composicion nutricional para mejorar la condicion de la piel e impedir las enfermedades de la piel | |
| NO20074318L (no) | Anvendelse av en fettsyresammensetning som inneholder DHA for fremstilling av et medisinsk produkt eller et naeringsmiddel for behandling av amyloidoserelaterte sykdommer | |
| WO2008149802A1 (ja) | アンドログラホリドを有効成分とする抗疲労剤及び経口組成物 | |
| BR112015000321A2 (pt) | formulações de laquinimod sem agente alcalinizante | |
| EP3318251A3 (en) | Composition for preventing or treating obesity or lipid-related metabolic disease | |
| BR112015027631A2 (pt) | Métodos para melhorar perfis de lipídeo usando atrasentana | |
| BRPI0715740A8 (pt) | Agente redutor de triglicerídeos séricos | |
| UA96794C2 (ru) | Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе | |
| BR112012021445B8 (pt) | formulação farmacêutica ou neutracêutica, e uso de um agente promotor de biodisponibilidade |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: ASAHI CALPIS WELLNESS CO., LTD. (JP) |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2475 DE 12-06-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |